HEALTHY ADULT PARTICIPANTS

This is the first time a new drug called CPV-104 is being tested in people. The study aims to see if it is safe and how the body handles it in healthy adults and in patients with C3 glomerulopathy (C3G), a very rare and serious kidney disease. The main goal is to check for side e…

This study is testing a new nasal spray called RIG-101 to see if it can help prevent asthma flare-ups triggered by common cold viruses. First, researchers will check if the spray is safe in healthy people and adults with asthma. Then, they will give the spray to adults with asthm…

This is the first time a new drug called BGB-45035 is being tested in people. The main goal is to check if it is safe and how the body processes it. The study will first give the drug to healthy volunteers at different doses. Later, a small group of adults with itchy skin conditi…

This study is testing a new imaging tracer called [18F]GATT-44 to see how it moves through the body and brain during PET scans. Researchers are enrolling 32 healthy adults to measure how the tracer behaves, how much radiation it delivers, and how consistently it works. The goal i…

This early-stage study aims to understand how a new drug called SIM0270 interacts with other common medications in the body. Researchers will enroll 60 healthy Chinese adults to measure how SIM0270's levels in the blood change when taken with other drugs. The goal is to gather ba…

This is the first study testing a new drug called TBD11 in people. Researchers will give the drug to healthy adult volunteers to check for side effects and see how the body processes it. The study will test single and multiple doses, and also see if food affects how the drug work…

This study aims to test a Turkish version of a questionnaire designed to measure what parents and future parents know and think about toxic chemicals in the environment and how they affect children's health. Researchers will enroll 204 healthy adults to see if the questionnaire i…

This is the first study to test ADX-626 in people. Researchers will give the drug to 44 healthy adults to check if it's safe and how the body processes it. They'll also measure how it affects certain blood clotting factors.